Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1988-07-20
1992-06-02
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, 435 692, C07K 710
Patent
active
051186683
ABSTRACT:
Peptides having essentially the sequence of bovine pancreatic trypsin inhibitor (aprotinin) wherein one or more of the amino acids at positions 15, 16, 17, 18, 34, 39 and 52 are replaced by any naturally occurring amino acid produced by recombinant DNA technology, process, expression vector and recominant host therefor and pharmaceutical use thereof. Such peptides being useful as therapeutic agents in diseases connected with the presence of excessive amounts of proteinases.
REFERENCES:
Wunderer et al. 1981, Methods in Enzymology 80:816-820.
Wachter et al. 1980, Febs. Lett. 119(1):58-62.
Kato, I. 1979, Fed. Proc. 38:832, Abstract No. 3168.
Hochstrasser et al. 1985, Biol. Chem. Hoppe-Seyler vol. 366:473-478.
Strydom et al. 1981, Hoppe-Seyler's Physiol. Chem. 362:1377-1384.
Kingston et al. 1986, Biochem. J. 233-443-450.
Bowie et al. 1990, Science 247:1306-1310.
Dayhoff et al. 1972, Atlas of Protein Sequence and Structure 5:89-99.
Tschesche et al. 1983, Adv. Exp. Med. Biol. 156A:329-337.
Tschesche et al. 1987, Biochimica et Biophysica Acta 913:97-101.
Biochemistry, vol. 16, No. 8, Apr. 19, 1977, pp. 1531-1541, Tan et al., Synthesis and characterization of a pancreatic trypsin inhibitor homologue and a model inhibitor.
The Journal of Biological Chemistry, vol. 260, No. 21, Sep. 25, 1986, pp. 11451-11455, E. Fioretti et al., Primary structure and antiproteolytic activity of a Kunitz-type inhibitor from Bovine spleen.
EMBO Journal, vol. 5, No. 12, 1986, pp. 3219-3225, B. von Wilcken-Bergmann et al., A synthetic operon containing 14 bovine pancreatic trypsin inhibitor genes is expressed in E. coli.
ADV. Exp. Med. Biol., 1983, pp. 329-337; H. Tschesche et al., Peptide/protein inhibitors of tryspin and kallikrein-primary structural requirements.
Journal of Biological Chemistry, vol. 261, No. 15, Jun. 5, 1986, pp. 7115-7118, C. Berman Marks et al., Production of native, correctly folded bovine pancreatic trypsin inhibitor by Escherichia coli.
Auerswald Ernst-August
Bruns Wolfgang
Horlein Dietrich
Reinhardt Gerd
Schnabel Eugen
Bayer Aktiengesellschaft
Furman Keith C.
Wax Robert A.
LandOfFree
Variants of bovine pancreatic trypsin inhibitor and pharmaceutic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Variants of bovine pancreatic trypsin inhibitor and pharmaceutic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Variants of bovine pancreatic trypsin inhibitor and pharmaceutic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2228452